These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7856614)

  • 41. Cytomegalovirus infection after liver transplantation.
    Chen YS; Chen CL; Kuo YC; Sun CK
    Transplant Proc; 1994 Aug; 26(4):2229-30. PubMed ID: 8066728
    [No Abstract]   [Full Text] [Related]  

  • 42. Hyperimmune globulin prophylaxis for cytomegalovirus infection in renal transplantation.
    Wirnsberger GH; Mauric A; Holzer H
    Nephron; 1999; 81(3):368-9. PubMed ID: 10050103
    [No Abstract]   [Full Text] [Related]  

  • 43. Down regulation of in vivo and in vitro T cell responses post cytomegalovirus immune globulin intravenous (human) administration in sensitized renal transplant candidates.
    SivaSai KS; Mohanakumar T; Phelan D; Martin S; Anstey ME; Brennan DC
    Transplant Proc; 1999; 31(1-2):1378-81. PubMed ID: 10083610
    [No Abstract]   [Full Text] [Related]  

  • 44. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
    Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
    J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
    Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized controlled trial of sequential intravenous and oral ganciclovir versus prolonged intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in high-risk cytomegalovirus-seronegative liver transplant recipients with cytomegalovirus-seropositive donors.
    Winston DJ; Busuttil RW
    Transplantation; 2004 Jan; 77(2):305-8. PubMed ID: 14742998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group.
    Atkinson K; Arthur C; Bradstock K; Dale B; Downs K; Gibson J; Golenia M; Ho J; Joshua D; Juttner C
    Bone Marrow Transplant; 1995 Sep; 16(3):401-5. PubMed ID: 8535313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and therapy of cytomegalovirus disease after liver transplantation.
    Wiens M; Lefèbre B; Blumhardt G; Schmidt CA; Lohmann R; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1985-6. PubMed ID: 8385829
    [No Abstract]   [Full Text] [Related]  

  • 49. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
    Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
    Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis.
    Snydman DR
    Clin Transplant; 1995 Dec; 9(6):490-1. PubMed ID: 8645893
    [No Abstract]   [Full Text] [Related]  

  • 51. Cytomegalovirus infection and prophylaxis in heart transplantation.
    Laske A; Gallino A; Carrel T; Niederhäuser U; von Segesser LK; Turina MI
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1427-8. PubMed ID: 8382870
    [No Abstract]   [Full Text] [Related]  

  • 52. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens.
    Maurer JR; Snell G; deHoyos A; Kesten S; Winton T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1434-5. PubMed ID: 8382872
    [No Abstract]   [Full Text] [Related]  

  • 54. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation.
    Wiesner RH; Marin E; Porayko MK; Steers JL; Krom RA; Paya CV
    Gastroenterol Clin North Am; 1993 Jun; 22(2):351-66. PubMed ID: 8389735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients.
    DesJardin JA; Cho E; Supran S; Gibbons L; Werner BG; Snydman DR
    Clin Infect Dis; 2001 Oct; 33(8):1358-62. PubMed ID: 11565077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
    Iberer F; Halwachs-Baumann G; Rödl S; Pleisnitzer A; Wasler A; Auer T; Petutschnigg B; Müller H; Tscheliessnigg K; Wilders-Truschnig M
    J Heart Lung Transplant; 1994; 13(3):405-11. PubMed ID: 8061015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The prevention and treatment of cytomegalovirus infection after liver transplantation].
    Zheng SS; Jiang ZJ; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Lu AW
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):584-6. PubMed ID: 15938930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.